China Clot Management Devices Market Size & Outlook
Related Markets
China clot management devices market highlights
- The China clot management devices market generated a revenue of USD 49.2 million in 2023 and is expected to reach USD 79.8 million by 2030.
- The China market is expected to grow at a CAGR of 7.2% from 2024 to 2030.
- In terms of segment, percutaneous thrombectomy devices was the largest revenue generating product in 2023.
- Neurovascular Embolectomy Devices is the most lucrative product segment registering the fastest growth during the forecast period.
Clot management devices market data book summary
| Market revenue in 2023 | USD 49.2 million |
| Market revenue in 2030 | USD 79.8 million |
| Growth rate | 7.2% (CAGR from 2023 to 2030) |
| Largest segment | Percutaneous thrombectomy devices |
| Fastest growing segment | Neurovascular Embolectomy Devices |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Neurovascular Embolectomy Devices, Embolectomy Balloon Catheters, Percutaneous Thrombectomy Devices, Catheter-directed thrombolysis (CDT) devices, Inferior vena cava filters (IVCF) |
| Key market players worldwide | Medtronic PLC, Boston Scientific Corp, Teleflex Inc, Edwards Lifesciences Corp, LeMaitre Vascular Inc, Cook Medical, DePuy Synthes, iVascular, Vascular Solutions |
Other key industry trends
- In terms of revenue, China accounted for 2.7% of the global clot management devices market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, Japan clot management devices market is projected to lead the regional market in terms of revenue in 2030.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 79.8 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Clot Management Devices Market Scope
Clot Management Devices Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Vascular Solutions | View profile | 501-1000 | Minneapolis, Minnesota, United States, North America | http://www.vascularsolutions.com |
| iVascular | View profile | 51-100 | Barcelona, Catalonia, Spain, Europe | http://www.ivascular.global/ |
| LeMaitre Vascular Inc | View profile | 630 | 63 Second Avenue, Burlington, MA, United States, 01803 | https://www.lemaitre.com |
| Cook Medical | View profile | 10001+ | Bloomington, Indiana, United States, North America | http://www.cookmedical.com |
| Edwards Lifesciences Corp | View profile | 19800 | One Edwards Way, Irvine, CA, United States, 92614 | https://www.edwards.com |
| DePuy Synthes | View profile | 5001-10000 | Raynham, Massachusetts, United States, North America | https://depuysynthes.com |
| Teleflex Inc | View profile | 14500 | 550 East Swedesford Road, Suite 400, Wayne, PA, United States, 19087 | https://www.teleflex.com |
| Boston Scientific Corp | View profile | 48000 | 300 Boston Scientific Way, Marlborough, MA, United States, 01752-1234 | https://www.bostonscientific.com |
| Medtronic PLC | View profile | 95000 | Lower Hatch Street, 20 On Hatch, Dublin, Ireland, 2 | https://www.medtronic.com |
China clot management devices market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to clot management devices market will help companies and investors design strategic landscapes.
Percutaneous thrombectomy devices was the largest segment with a revenue share of 35.98% in 2023. Horizon Databook has segmented the China clot management devices market based on neurovascular embolectomy devices, embolectomy balloon catheters, percutaneous thrombectomy devices, catheter-directed thrombolysis (cdt) devices, inferior vena cava filters (ivcf) covering the revenue growth of each sub-segment from 2018 to 2030.
A significant increase in the burden of cardiovascular diseases, including thrombotic disorders, has been recorded in China leading to the growth of clot management devices. Lifestyle changes, urbanization, and an aging population are contributing to the rising incidence of clot-related conditions.
This is driving the demand for clot management devices to address the growing healthcare needs. Furthermore, the Chinese government has implemented various initiatives and healthcare reforms to improve healthcare access and quality nationwide.
These reforms have led to increased investment in healthcare infrastructure, expansion of healthcare insurance coverage, and improved reimbursement policies for medical devices, including clot management devices. For example, List A medical devices are reimbursed 100% with less than a 10% co-pay and List B devices have a 20% to 60% co-pay option. The clot management devices market commonly belongs to List B.
Reasons to subscribe to China clot management devices market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of China clot management devices market databook
-
Our clientele includes a mix of clot management devices market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the China clot management devices market , including forecasts for subscribers. This country databook contains high-level insights into China clot management devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
China clot management devices market size, by product, 2018-2030 (US$M)
China Clot Management Devices Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
